During the past decade, Suncoast Neuroscience Associates, Inc. conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 13 clinical trials were completed, i.e. on average, 68.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Suncoast Neuroscience Associates, Inc." #1 sponsor was "Avanir Pharmaceuticals" with 4 trials, followed by "Eisai Inc." with 4 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Suncoast Neuroscience Associates, Inc." #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Syneos Health" with 3 trials as a collaborator, "Alquest" with 1 trials as a collaborator and "Amsterdam UMC, location VUmc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Suncoast Neuroscience Associates, Inc." are "Parkinson's Disease" (9 trials), "Alzheimer's Disease" (7 trials), "Alzheimer Disease" (6 trials), "Multiple Sclerosis" (4 trials) and "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials). Many other conditions were trialed in "Suncoast Neuroscience Associates, Inc." in a lesser frequency.

Most popular intervention types in "Suncoast Neuroscience Associates, Inc." are "Drug" (44 trials), "Other" (5 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "AVP-786" (2 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "E2007" (2 trials). Other intervention names were less common.

The vast majority of trials in "Suncoast Neuroscience Associates, Inc." are 47 trials for "All" genders.

Currently, there are NaN active trials in "Suncoast Neuroscience Associates, Inc.". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Suncoast Neuroscience Associates, Inc., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Suncoast Neuroscience Associates, Inc., 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".